Another Pipeline Diabetes Drug Looks Beneficial
(MedPage Today) -- The investigational SGLT2 inhibitor remogliflozin showed benefits for glucose lowering in type 2 diabetes.
Source: MedPage Today Cardiovascular - Category: Cardiology Source Type: news
More News: Cardiology | Cardiovascular | Diabetes | Diabetes Type 2 | Endocrinology | Heart | SGLT2 Inhibitors